+60.2%
EMR vs FLNC
-62.9%
+123.1%
-29.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | FLNC | Excess | Alpha |
|---|---|---|---|---|
| 1D | +2.6% | +2.5% | +0.1% | +2.4% |
| 7D | -0.4% | -4.1% | +3.6% | -0.1% |
| 30D | -6.8% | -24.8% | +18.0% | -4.7% |
| 3M | +7.5% | -59.1% | +66.6% | +14.7% |
| 6M | +9.9% | -42.0% | +51.8% | +11.7% |
| YTD | +16.0% | -49.8% | +65.8% | +18.2% |
| 1Y | +12.4% | +43.1% | -30.6% | +1.2% |
| 3Y | +60.2% | -61.0% | +121.2% | +49.0% |
| All | +60.2% | -62.9% | +123.1% | +49.0% |
Cumulative growth
Daily Returns
Daily percentage return beside FLNC.
Daily Out/Under-Performance
Portfolio return minus FLNC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × FLNC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded FLNC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling